Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glenmark Life Sciences LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543322NSE Symbol: GLSP/E(TTM):29.38
ISIN Demat:INE03Q201024Div & Yield %:2.22EPS(TTM):34.56
Book Value(Rs):207.1743448Market Cap ( Cr.):12439.72Face Value(Rs):2
    Change Company 
(Rs In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
SOURCES OF FUNDS :      
Share Capital 24.5124.5124.511.961.961.96
Reserves Total 2307.822113.702029.81750.79399.7386.17
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2332.332138.212054.32752.75401.6988.13
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 17.1519.362.880.000.020.02
Total Debt17.1519.362.880.000.020.02
Other Liabilities15.777.870.000.000.000.00
Total Liabilities2365.252165.442057.20752.75401.7188.15
APPLICATION OF FUNDS :      
Gross Block 1012.33936.48705.53651.90594.82475.57
Less : Accumulated Depreciation 207.26155.85115.7779.1048.5819.26
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 805.07780.63589.76572.80546.24456.31
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress105.9961.6296.9614.1010.7380.39
Producing Properties0.000.000.000.000.000.00
Investments 0.080.080.080.080.080.08
Current Assets, Loans & Advances      
Inventories 666.59604.17516.24513.42412.78400.84
Sundry Debtors 765.43806.77673.49619.50638.63448.09
Cash and Bank301.59309.40512.16115.6010.002.06
Loans and Advances 182.38130.0162.69150.5298.7179.70
Total Current Assets1916.001850.341764.591399.041160.12930.69
Less : Current Liabilities and Provisions      
Current Liabilities 424.35479.53355.881187.851285.101364.00
Provisions 12.0314.7526.4433.6022.3416.40
Total Current Liabilities436.38494.28382.321221.441307.441380.39
Net Current Assets1479.621356.071382.27177.59-147.33-449.70
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets4.551.811.072.030.132.29
Deferred Tax Liability53.3444.2532.5724.9116.589.14
Net Deferred Tax-48.79-42.44-31.50-22.88-16.45-6.85
Other Assets23.299.4919.6311.068.447.92
Total Assets2365.252165.452057.20752.75401.7288.15
Contingent Liabilities4.822.222.222.222.222.76